MAPP Related Analyst Ratings
-
Leerink Swann Upgrades MAP Pharmaceuticals (MAPP) to Outperform
-
Deutsche Bank Upgrades MAP Pharmaceuticals (MAPP) to Buy
-
Bank of America Upgrades MAP Pharmaceuticals (MAPP) to Buy
-
Leerink Swann Downgrades MAP Pharmaceuticals (MAPP) to Market Perform
-
Deutsche Bank Downgrades MAP Pharmaceuticals (MAPP) to Hold, Lowers Estimates & Price Target
-
Bank of America Downgrades MAP Pharmaceuticals (MAPP) to Neutral
-
Merrill Lynch Initiates Coverage on MAP Pharmaceuticals (MAPP) with a Buy
Back to MAPP Stock Lookup
